Company: NIVFW
Filing Date: 2025-04-22
Form Type: 20-F
Source: 0001213900-25-033966
Chunk: 150

Company: NewGenIvf Group Ltd
Filing Date: 2025-04-22
Form: 20-F
Item: Item 19
Chunk 150
---
848         ( 94,452  
  CASH FLOWS FROM FINANCING ACTIVITIES                                                                                                                                       
  Amount due from A SPAC I                                                                                            140,000                    ( 140,000                —  
  Finance lease                                                                                                       ( 6,446                      ( 9,317         ( 19,476  
  Other borrowings, net                                                                                             8,583,597                            —          128,204  
  Issuance of shares (net of reverse capitalization effect)                                                                 -                      192,308                —  
  Interest paid                                                                                                     ( 677,663                     ( 24,704                —  
  Amount with related parties                                                                                         508,738                    1,863,206      ( 1,742,509  
  Subscription receivable                                                                                             127,564                            -                -  
  Net cash provided by (used in) financing activities                                                               8,675,790                    1,881,493      ( 1,633,781  
  Net increase/(decrease) in cash and cash equivalents                                                                358,671                       45,510         ( 17,332  
  Effect of foreign currency translation on cash and cash equivalents                                                  44,965                     ( 18,962           16,124  
  Cash and cash equivalents, beginning of year                                                                         54,104                       27,556           28,764  
  Cash and cash equivalents, end of year                                                        $                     457,740      $                54,104           27,556  
  Supplementary cash flow information:                                                                                                                                       
  Taxes paid                                                                                    $                           —      $                     —         ( 12,170  
  Interest paid                                                                                 $                   ( 768,068      $              ( 24,704         ( 55,469  

  Re-presented as mentioned in Note 23  

During the year ended December 31, 2024, no cash was exchanged in respect
of these transactions:

  $2,650,000 of convertible debt was converted into equity.  

  Reversal arising from remeasurement of share-based compensation within prepayment amounting to $2,739,856.  

The accompanying notes are an integral part of
these consolidated financial statements.

F-7

NEWGENIVF GROUP LIMITED

NOTE 1 - ORGANIZATION AND PRINCIPAL ACTIVITIES

Prior to the Business Combination,
on April 29, 2021, A SPAC I Acquisition